These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33504304)

  • 1. Application and Future Prospect of Extracellular Matrix Targeted Nanomaterials in Tumor Theranostics.
    Fang W; Su D; Lu W; Wang N; Mao R; Chen Y; Ge K; Shen A; Hu R
    Curr Drug Targets; 2021; 22(8):913-921. PubMed ID: 33504304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
    Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK
    Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Theranostic Applications of Nanomaterials in Cancer.
    Ahmed F; Khan MA; Haider N; Ahmad MZ; Ahmad J
    Curr Pharm Des; 2022; 28(2):133-150. PubMed ID: 34530703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactive inorganic nanomaterials for cancer theranostics.
    Pei Z; Lei H; Cheng L
    Chem Soc Rev; 2023 Mar; 52(6):2031-2081. PubMed ID: 36633202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
    Tripathi P; Shukla P; Bieberich E
    Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of Two-Dimensional Nanomaterials in Breast Cancer Theranostics.
    Mohammadpour Z; Majidzadeh-A K
    ACS Biomater Sci Eng; 2020 Apr; 6(4):1852-1873. PubMed ID: 33455353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inorganic nanomaterials with rapid clearance for biomedical applications.
    Wang X; Zhong X; Li J; Liu Z; Cheng L
    Chem Soc Rev; 2021 Aug; 50(15):8669-8742. PubMed ID: 34156040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2D Nanomaterials for Cancer Theranostic Applications.
    Cheng L; Wang X; Gong F; Liu T; Liu Z
    Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.
    Ma Y; Huang J; Song S; Chen H; Zhang Z
    Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications.
    Ahmad J; Rizwanullah M; Suthar T; Albarqi HA; Ahmad MZ; Vuddanda PR; Khan MA; Jain K
    Crit Rev Ther Drug Carrier Syst; 2022; 39(6):1-44. PubMed ID: 35997100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease-activated nanomaterials for targeted cancer theranostics.
    Chan YC; Hsiao M
    Nanomedicine (Lond); 2017 Sep; 12(18):2153-2159. PubMed ID: 28814163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Progress in 808 nm Excited Upconversion Nanomaterials as Multifunctional Nanoprobes for Visualized Theranostics in Cancers.
    Zeng L; Wu D; Tian Y; Pan Y; Wu A; Zhang J; Lu G
    Curr Med Chem; 2018; 25(25):2954-2969. PubMed ID: 28322153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances of Emerging Metal-Containing Two-Dimensional Nanomaterials in Tumor Theranostics.
    Li C; Fang X; Zhang H; Zhang B
    Int J Nanomedicine; 2024; 19():805-824. PubMed ID: 38283201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional gadolinium-based nanoscale systems for cancer theranostics.
    Li H; Zeng Y; Zhang H; Gu Z; Gong Q; Luo K
    J Control Release; 2021 Jan; 329():482-512. PubMed ID: 32898594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomaterials for Nanotheranostics: Tuning Their Properties According to Disease Needs.
    Wong XY; Sena-Torralba A; Álvarez-Diduk R; Muthoosamy K; Merkoçi A
    ACS Nano; 2020 Mar; 14(3):2585-2627. PubMed ID: 32031781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembled Nucleic Acid Nanostructures for Cancer Theranostic Medicines.
    Fu J; Stankeviciute G; Oh SW; Collins J; Zhong Y; Zhang T
    Curr Top Med Chem; 2017; 17(16):1815-1828. PubMed ID: 27875979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Assessment of In-vitro and In-vivo Evaluation Methods for Theranostic Nanomaterials.
    Parashar P; Singh N; Alka ; Maurya P; Saraf SA
    Curr Pharm Des; 2022; 28(2):78-90. PubMed ID: 34348616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and Functionalization of the NIR-Responsive Photothermal Semiconductor Nanomaterials for Cancer Theranostics.
    Huang X; Zhang W; Guan G; Song G; Zou R; Hu J
    Acc Chem Res; 2017 Oct; 50(10):2529-2538. PubMed ID: 28972736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics.
    Ang MJY; Chan SY; Goh YY; Luo Z; Lau JW; Liu X
    Adv Drug Deliv Rev; 2021 Nov; 178():113907. PubMed ID: 34371084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.